InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: slimhere post# 187709

Thursday, 04/18/2019 11:01:21 AM

Thursday, April 18, 2019 11:01:21 AM

Post# of 426692
I know, Amarin would become particularly valuable in an environment with price controls BARRING some legislation that speeds up the generic drug timeline. As a low cost drug, that can do high volume Vascepa would not be effected otherwise. The MOST likely scenario that could actually pass legislation is making Medicare a buy in program down to age 55. Maybe putting some limits on older drugs and pricing. I just don't see an election getting either party enough control to do major overhauls.

Most of this computer trading day to day is not Amarin specific so it gets lumped in, in the long run sales will determine where it goes not the sector. There are positive moving stocks in a bear market, there can be positive moving biotech stocks when the sector is down
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News